xIANDING (Victor) MA | PARTNER | PARIS

Founder of Cenponts, Europe-based for over 15 years, with a proven track record in cross-border investments, M&A, and licensing transactions totaling several billion USD; Received a congratulatory letter from the Office of French President Emmanuel Macron in 2018.

  • •Domain Therapeutics (Series A Funding: $42M)

    •Avilex Pharma & Simcere (Licensing: $175M)

    •Skymedic & Wondfo (Licensing: $21M)

    •Genfit & Terns Pharma (Licensing: $228M)

    •Pharnext & Tasly (Equity: $30M), etc.

  • •Master Degree, École Centrale Paris & École Nationale des Ponts et Chaussées (IP Paris)